Work

Abstract 2318: BET bromodomain inhibitors for cancer therapy

Year: 2011

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2011-2318

Authors: Jun Qi, Panagis Filippakopoulos, Michael McKeown, Katharin L. Shaw, William B. Smith, Christopher A. French, Andrew L. Kung, Stefan Knapp, James E. Bradner

Institutions: Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, University of Oxford, Brigham and Women's Hospital

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1964523693

Cites:

Cited by:

Related to: 10